Interventional Cultural and Language Assistance Program: Associations between Cultural and Linguistic Factors and Satisfaction with Cancer Care.
Costas Muniz R , Amir J , Paris M , Spratt D
Journal of community medicine & health education 7 ( 1) 503
1
2017
Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
Pat B Zanzonico , Sarah M Cheal , Steven M Larson , Joseph Reginald Osborne
2020
Genetic analysis of the establishment and maintenance of the olfactory topographic map
Joseph Reginald Osborne
Columbia University
2001
PSMA targeted SPECT imaging biomarker to detect local and metastatic prostate cancer (PCa): Phase I studies with 99mTc-MIP-1404
Irina Lipai , John Joyal , Scott Tagawa , Douglas Scherr
The Journal of Nuclear Medicine 54 281 -281
6
2013
All about Y-90 radio-embolic therapy: Practice patterns and patient safety
Stanley Goldsmith , Joseph Osborne , Shankar Vallabhajosula , Bradley Pua
The Journal of Nuclear Medicine 52 1078 -1078
2011
Reliable index of tumor targeting in RIT with 177Lu-J591 monoclonal antibody in patients with metastatic prostate cancer
Shankar Vallabhajosula , Neil Bander , Scott Tagawa , Stanley Goldsmith
Society of Nuclear Medicine Annual Meeting Abstracts 52 1758
2011
Dose fractionation (DF) and combination radioimmunotherapy (RIT) in patients with prostate cancer using 177Lu-J591 (Lu-J591) anti-PSMA antibody and docetaxel
Irina Lipai , Scott Tagawa , Stanley Goldsmith , Anastasia Nikolopoulou
The Journal of Nuclear Medicine 52 360 -360
2011
Ex vivo SPECT/CT imaging of prostate cancer via 111In-J591 monoclonal antibody
Douglas Scherr , Kofi Deh , Joseph Osborne , Bradley Beattie
The Journal of Nuclear Medicine 54 282 -282
2013
123I-Ioflupane SPECT in early Parkinson syndrome
Stanley Goldsmith , Caitlin Hardy , Joseph Osborne , James Toby
Society of Nuclear Medicine Annual Meeting Abstracts 53 1049
2012
Quantitative SPECT imaging with Lu-177: A physical phantom evaluation
Stanley Goldsmith , Anastasia Nikolopoulou , Joseph Osborne , Bin He
The Journal of Nuclear Medicine 53 2407 -2407
6
2012
Small molecule inhibitors of prostate specific membrane antigen (PSMA) for SPECT: Summary of phase I studies in patients with prostate cancer (PCa)
John Joyal , John Babich , Stanley Goldsmith , R. Edward Coleman
Society of Nuclear Medicine Annual Meeting Abstracts 53 179
2
2012
Effect of specific activity on the uptake of [68Ga]-DKFZ-PSMA11 in tumor and other organs
Teja Kalidindi , NagaVaraKishore Pillarsetty , Joseph Osborne , Sean Carlin
The Journal of Nuclear Medicine 57 528 -528
2
2016
111In-J591 scan to predict PSMA targeting and treatment response following RIT with 177Lu-J591 monoclonal antibody in patients with metastatic prostate cancer
Scott Tagawa , Stanley Goldsmith , Joseph Osborne , Masaya Kawano
Society of Nuclear Medicine Annual Meeting Abstracts 51 173
2
2010
Three-fold reduction in pediatric PET dose by advanced image reconstruction without loss of diagnostic and quantitative performance
Pat Zanzonico , Neeta Pandit-Taskar , Ida Haggstrom , Lawrence Dauer
The Journal of Nuclear Medicine 59 583 -583
2018
Pilot study of anti-prostate-specific membrane antigen (PSMA) antibody J591 for men with metastatic castration-resistant prostate cancer (mCRPC) and unfavorable circulating tumor cell (CTC) count.
Paul J. Christos , David M. Nanus , Scott T. Tagawa , John Babich
Journal of Clinical Oncology 39 120 -120
2021
A phase I/II dose-escalation study of fractionated and multiple dose 225Ac-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC).
Paul J. Christos , David M. Nanus , Scott T. Tagawa , John Babich
Journal of Clinical Oncology 39
2021
Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC).
David M. Nanus , Scott T. Tagawa , Cora N. Sternberg , Jones T. Nauseef
Journal of Clinical Oncology 39 158 -158
2021
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer.
Matthew Milowsky , Scott Tagawa , Dana Rathkopf , Dana Rathkopf
Clinical Genitourinary Cancer
2021
What’s trust got to do with it? social and demographic predictors of trust in cancer information among brooklyn, NY residents
Joseph Osborne , Marlene Camacho-Rivera
APHA's 2020 VIRTUAL Annual Meeting and Expo (Oct. 24 - 28)
2020
Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer
Valerie Longo , Hong-fen Guo , Guangbin Yang , Joseph Osborne
Nuclear Medicine and Biology
2021